Detalhe da pesquisa
1.
Private Payer and Medicare Coverage Policies for Use of Circulating Tumor DNA Tests in Cancer Diagnostics and Treatment.
J Natl Compr Canc Netw
; 21(6): 609-616.e4, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37308126
2.
The Health Inequality Impact of Liquid Biopsy to Inform First-Line Treatment of Advanced Non-Small Cell Lung Cancer: A Distributional Cost-Effectiveness Analysis.
Value Health
; 26(12): 1697-1710, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37741446
3.
Pain-Related Stigma and Its Associations With Clinical and Experimental Pain Severity in Youth With Chronic Musculoskeletal Pain Conditions.
J Pediatr Psychol
; 48(10): 842-851, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37500594
4.
US private payers' perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER).
Genet Med
; 24(1): 238-244, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34906461
5.
Influence of payer coverage and out-of-pocket costs on ordering of NGS panel tests for hereditary cancer in diverse settings.
J Genet Couns
; 31(1): 130-139, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34231930
6.
Genetic counselors' experience with reimbursement and patient out-of-pocket cost for multi-cancer gene panel testing for hereditary cancer syndromes.
J Genet Couns
; 31(6): 1394-1403, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35900261
7.
Private payer coverage policies for ApoE-e4 genetic testing.
Genet Med
; 23(4): 614-620, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33420342
8.
Laboratory business models and practices: implications for availability and access to germline genetic testing.
Genet Med
; 23(9): 1681-1688, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33958748
9.
Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequencing: Results of a study from the Program in Prenatal and Pediatric Genomic Sequencing (P3EGS).
Genet Med
; 22(2): 283-291, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31501586
10.
Private Payer and Medicare Coverage for Circulating Tumor DNA Testing: A Historical Analysis of Coverage Policies From 2015 to 2019.
J Natl Compr Canc Netw
; 18(7): 866-872, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32634780
11.
Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing-Based Tests: Challenges, Opportunities, and Potential Solutions.
Value Health
; 23(5): 540-550, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32389218
12.
Insights From a Temporal Assessment of Increases in US Private Payer Coverage of Tumor Sequencing From 2015 to 2019.
Value Health
; 23(5): 551-558, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32389219
13.
Quantifying Downstream Healthcare Utilization in Studies of Genomic Testing.
Value Health
; 23(5): 559-565, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32389220
14.
Private payer coverage policies for exome sequencing (ES) in pediatric patients: trends over time and analysis of evidence cited.
Genet Med
; 21(1): 152-160, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29997388
15.
The State of State Biomarker Testing Insurance Coverage Laws.
JAMA
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38739406
16.
Corrigendum: What are people willing to pay for whole-genome sequencing information, and who decides what they receive?
Genet Med
; 20(1): 165, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29261179
17.
Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial.
Genet Med
; 20(12): 1544-1553, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29565423
18.
Cost Analyses of Genomic Sequencing: Lessons Learned from the MedSeq Project.
Value Health
; 21(9): 1054-1061, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30224109
19.
Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions.
Value Health
; 21(9): 1033-1042, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30224106
20.
From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing.
Value Health
; 21(9): 1062-1068, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30224110